Ortholevo is a Boston-based pharmaceutical startup founded on a track record of innovation to commercialize treatments for fibrotic diseases of joints, muscles, and connective tissues. Our mission is to improve the lives of millions of patients around the world by providing freedom from fibrosis. Our technology safely and non-surgically treats fibrosis from neuromuscular diseases, musculoskeletal and congenital conditions, cosmetic ailments, inflammatory diseases, and many other pathologies. Having conducted proof-of-concept animal studies, we are now completing additional preclinical studies in preparation for a first-in-human clinical trial. Contact: [email protected]
External link for Ortholevo
Boston, US
Join this American Chemical Society Webinar tomorrow for discussion on applications of #Biomaterials in healthcare
Our experts are joined by Westlake University and Ortholevo to discuss #Biomaterials. Register for this webinar on August 14 to learn about the R&D efforts surrounding these materials and how they can reshape healthcare. https://ow.ly/HvYk50SWQBX #MedicalResearch
Exciting to see life science innovations from all over the state at MALSI Day 2024 at Innovation Studio in partnership with MassVentures, and excited to share that Ortholevo won Judges' Choice in the pitch competition. Thank you to all the judges, volunteers, and the entire team that put together this great event. Benjamin Cooper Ophélie Puisségur